Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B
β Scribed by Chung-Mau Lo; James Tak-Kwan Fung; George Ka-Kit Lau; Chi-Leung Liu; Siu-Tim Cheung; Ching-Lung Lai; Sheung-Tat Fan; John Wong
- Book ID
- 111722103
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 123 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Antibody to hepatitis B surface antigen (HBsAg) (antiβHBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and antiβHBs (concurrent HBsAg/ antiβHBs) with hepatocellular carcinoma (HCC). The aim of t
"Escape" variants of hepatitis B virus (HBV) can cause infection despite previous immunization. These viruses show alterations of the immunogenic major hydrophilic loop of the HBV small surface protein (s-protein). We studied whether HBV "escape" variants were selected in patients with graft infecti
Hepatitis B virus (HBV) reinfection and recurrence of hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT) are associated with increased graft failure and reduced patient survival. We evaluated the effects of both HCC recurrence and HBV reinfection on the long-term survival of
Hepatitis B immunoglobulin (HBIG) administration remains an essential component of standard reinfection prophylaxis after liver transplantation for hepatitis B virus-related liver disease. Previous studies have suggested that intramuscular (IM) HBIG administration compared to intravenous (IV) HBIG a